Publications

Detailed Information

Low blood levels of lead and mercury and symptoms of attention deficit hyperactivity in children: A report of the children`s health and environment research (CHEER)

DC Field Value Language
dc.contributor.authorHa, Mina-
dc.contributor.authorKwon, Ho-Jang-
dc.contributor.authorLim, Myung-Ho-
dc.contributor.authorJee, Young-Koo-
dc.contributor.authorLeem, Jong-Han-
dc.contributor.authorBae, Jong-Myun-
dc.contributor.authorRoh, Young-Man-
dc.contributor.authorJo, Seong-Joon-
dc.contributor.authorHong, Soo-Jong-
dc.contributor.authorSakong, June-
dc.contributor.authorHong, Yun-Chul-
dc.date.accessioned2012-06-08T07:19:47Z-
dc.date.available2012-06-08T07:19:47Z-
dc.date.issued2009-01-
dc.identifier.citationNEUROTOXICOLOGY; Vol.30 1; 31-36ko_KR
dc.identifier.issn0161-813X-
dc.identifier.urihttps://hdl.handle.net/10371/76912-
dc.description.abstractBackground: The goal of this study was to examine the association between low levels of lead and mercury in blood and symptoms of attention-deficit hyperactivity disorder (ADHD) among Korean children. Methods: One thousand seven hundred and seventy eight children at 10 elementary schools in six South Korea cities participated in this study. Parents and guardians administered a questionnaire including Conners` parents rating ADHD scale to determine the presence of ADHD symptoms. In addition, clinical examinations of the children and determination of blood lead and mercury levels were included in the first Children`s Health and Environment Research (CHEER) survey, which is now conducted annually in Korea. Results: The risk for the appearance of ADHD symptoms was found to increase with the blood lead concentration. The mean blood lead concentration was low with a geometric mean of 1.8 mu g/dl. The odds ratios (95% confidence intervals) for the presence of ADHD symptoms were 1.28 (0.57, 2.86), 1.32 (0.63, 2.74), 1.65 (0.77, 3.56), and 1.98 (0.76. 5.13) in children with blood lead levels of 1-<1.5, -<2.5, -<3.5, and >3.5 mu g/dl, compared to those with blood lead levels of <1.0 mu g/dl: these results statistically represented a borderline trend (p for trend: 0.07). The blood lead level showed a significant positive association with the Conners` ADHD score (beta = 0.50, p < 0.0001). However, the blood mercury levels were not found to be significantly associated with ADHD symptoms in children. The geometric mean mercury concentration in the blood was 2.4 mu g/l. Conclusions: The observed association between blood lead concentration and the appearance of ADHD symptoms in Korean children suggests that lead, even at low concentrations, is a risk factor for ADHD. (C) 2008 Elsevier Inc. All rights reserved.ko_KR
dc.language.isoenko_KR
dc.publisherELSEVIER SCIENCE BVko_KR
dc.subjectADHDko_KR
dc.subjectLeadko_KR
dc.subjectMercuryko_KR
dc.titleLow blood levels of lead and mercury and symptoms of attention deficit hyperactivity in children: A report of the children`s health and environment research (CHEER)ko_KR
dc.typeArticleko_KR
dc.contributor.AlternativeAuthor하미나-
dc.contributor.AlternativeAuthor권호장-
dc.contributor.AlternativeAuthor임명호-
dc.contributor.AlternativeAuthor지영구-
dc.contributor.AlternativeAuthor홍윤철-
dc.contributor.AlternativeAuthor임종한-
dc.contributor.AlternativeAuthor배종면-
dc.contributor.AlternativeAuthor홍수종-
dc.contributor.AlternativeAuthor노영만-
dc.contributor.AlternativeAuthor조성준-
dc.contributor.AlternativeAuthor사공준-
dc.identifier.doi10.1016/j.neuro.2008.11.011-
dc.citation.journaltitleNEUROTOXICOLOGY-
dc.description.citedreferenceSpencer TJ, 2007, J PEDIATR PSYCHOL, V32, P631, DOI 10.1093/jpepsy/jsm005-
dc.description.citedreferenceBudtz-Jorgensen E, 2007, ENVIRON HEALTH PERSP, V115, P323, DOI 10.1289/ehp.9738-
dc.description.citedreferenceBraun JM, 2006, ENVIRON HEALTH PERSP, V114, P1904, DOI 10.1289/ehp.9478-
dc.description.citedreferenceBiederman J, 2005, LANCET, V366, P237-
dc.description.citedreferenceLanphear BP, 2005, ENVIRON HEALTH PERSP, V113, P894, DOI 10.1289/ehp.7688-
dc.description.citedreference*KOR HLTH INS REV, 2005, NAT HLTH INS STAT YB-
dc.description.citedreferenceHong SJ, 2004, CLIN EXP ALLERGY, V34, P1556, DOI 10.1111/j.1365-2222.2004.02084.x-
dc.description.citedreferenceKwong WT, 2004, SCI TOTAL ENVIRON, V330, P21, DOI 10.1016/j.scitotenv.2004.03.017-
dc.description.citedreferenceMyers GJ, 2003, LANCET, V361, P1686, DOI 10.1016/S0140-6736(03)13371-5-
dc.description.citedreferenceCanfield RL, 2003, NEW ENGL J MED, V348, P1517-
dc.description.citedreferenceWright RO, 2003, J PEDIATR, V142, P9, DOI 10.1067/mpd.2003.44-
dc.description.citedreferenceSO YY, 2003, J CHILD ADOL PSYCHOP, V14, P183-
dc.description.citedreferenceStein J, 2002, J DEV BEHAV PEDIATR, V23, pS13-
dc.description.citedreferenceLIM Y, 2002, KOREAN J COMM NUTR, V7, P58-
dc.description.citedreferenceSchettler T, 2001, ENVIRON HEALTH PERSP, V109, P813-
dc.description.citedreferenceWright RO, 1999, AM J PUBLIC HEALTH, V89, P1049-
dc.description.citedreferenceMendelsohn AL, 1998, PEDIATRICS, V101-
dc.description.citedreferenceGrandjean P, 1997, NEUROTOXICOL TERATOL, V19, P417-
dc.description.citedreferenceSCHWARTZ J, 1994, ENVIRON RES, V65, P42-
dc.description.citedreferenceFERGUSSON DM, 1993, J CHILD PSYCHOL PSYC, V34, P215-
dc.description.citedreferenceBELLINGER DC, 1992, PEDIATRICS, V90, P855-
dc.description.citedreferenceTHOMSON GOB, 1989, J CHILD PSYCHOL PSYC, V30, P515-
dc.description.citedreferenceKJELLSTROM T, 1989, PHYSICAL MENTAL DEV, P3642-
dc.description.citedreferenceSILVA PA, 1988, J CHILD PSYCHOL PSYC, V29, P43-
dc.description.citedreferenceNEEDLEMAN HL, 1982, NEUROBEH TOXICOL TER, V4, P729-
dc.description.citedreferenceNEEDLEMAN HL, 1979, NEW ENGL J MED, V300, P689-
dc.description.citedreferenceCHOI BH, 1978, J NEUROPATH EXP NEUR, V37, P719-
dc.description.tc16-
Appears in Collections:
Files in This Item:
There are no files associated with this item.

Altmetrics

Item View & Download Count

  • mendeley

Items in S-Space are protected by copyright, with all rights reserved, unless otherwise indicated.

Share